BACKGROUND: Pro-inflammatory cytokines produced primarily by macrophages are key elements in many surgical conditions including sepsis, ischemia-reperfusion injury, and transplant rejection. Herbal products are being used as alternative treatments in such inflammatory conditions. Ginger is known for its ethno-botanical applications as an anti-inflammatory agent. 6-gingerol is one of the active ingredients of ginger that imparts ginger with its anti-inflammatory properties. We hypothesized that the anti-inflammatory effect of 6-gingerol is because of inhibition of macrophage activation, more specifically by an inhibition of pro-inflammatory cytokines and antigen presentation by lipopolysaccharide (LPS) activated macrophages. METHODS: To study the effect of 6-gingerol on pro-inflammatory cytokines, we measured the liberation of TNF-alpha, IL-1beta, and IL-12 by murine peritoneal macrophages exposed to several doses of 6-gingerol in the presence of LPS stimulation. We also studied the effect of 6-gingerol on the cell surface expression of B7.1, B7.2, and MHC II. Finally, we examined the APC function of the 6-gingerol treated macrophages by a primary mixed lymphocyte reaction. RESULTS: 6-gingerol inhibited the production of pro-inflammatory cytokines from LPS stimulated macrophages but had no effect on the LPS-induced expression of B7.1, B7.2, and MHC II. The APC function of LPS stimulated macrophages was also unaffected by 6-gingerol treatment. CONCLUSION: Our data indicate that 6-gingerol selectively inhibits production of pro-inflammatory cytokines from macrophages but does not affect either the APC function or cell surface expression of MHC II and costimulatory molecules. We, thus, provide a mechanistic insight into the anti-inflammatory properties of 6-gingerol that may be useful to treat inflammation without interfering with the antigen presenting function of macrophages.
BACKGROUND: Pro-inflammatory cytokines produced primarily by macrophages are key elements in many surgical conditions including sepsis, ischemia-reperfusion injury, and transplant rejection. Herbal products are being used as alternative treatments in such inflammatory conditions. Ginger is known for its ethno-botanical applications as an anti-inflammatory agent. 6-gingerol is one of the active ingredients of ginger that imparts ginger with its anti-inflammatory properties. We hypothesized that the anti-inflammatory effect of 6-gingerol is because of inhibition of macrophage activation, more specifically by an inhibition of pro-inflammatory cytokines and antigen presentation by lipopolysaccharide (LPS) activated macrophages. METHODS: To study the effect of 6-gingerol on pro-inflammatory cytokines, we measured the liberation of TNF-alpha, IL-1beta, and IL-12 by murine peritoneal macrophages exposed to several doses of 6-gingerol in the presence of LPS stimulation. We also studied the effect of 6-gingerol on the cell surface expression of B7.1, B7.2, and MHC II. Finally, we examined the APC function of the 6-gingerol treated macrophages by a primary mixed lymphocyte reaction. RESULTS:6-gingerol inhibited the production of pro-inflammatory cytokines from LPS stimulated macrophages but had no effect on the LPS-induced expression of B7.1, B7.2, and MHC II. The APC function of LPS stimulated macrophages was also unaffected by 6-gingerol treatment. CONCLUSION: Our data indicate that 6-gingerol selectively inhibits production of pro-inflammatory cytokines from macrophages but does not affect either the APC function or cell surface expression of MHC II and costimulatory molecules. We, thus, provide a mechanistic insight into the anti-inflammatory properties of 6-gingerol that may be useful to treat inflammation without interfering with the antigen presenting function of macrophages.
Authors: Francisco A P Rodrigues; Mara M G Prata; Iris C M Oliveira; Natacha T Q Alves; Rosa E M Freitas; Helena S A Monteiro; Jame's A Silva; Paulo C Vieira; Daniel A Viana; Alexandre B Libório; Alexandre Havt Journal: Antimicrob Agents Chemother Date: 2014-01-06 Impact factor: 5.191
Authors: Mardi M Algandaby; Ali M El-Halawany; Hossam M Abdallah; Abdulrahman M Alahdal; Ayman A Nagy; Osama M Ashour; Ashraf B Abdel-Naim Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2016-01-26 Impact factor: 3.000
Authors: Gene T Yocum; Julie J Hwang; Maya Mikami; Jennifer Danielsson; Aisha S Kuforiji; Charles W Emala Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-12-04 Impact factor: 5.464
Authors: Marcela González-Gross; Carlos Quesada-González; Javier Rueda; Manuel Sillero-Quintana; Nicolas Issaly; Angel Enrique Díaz; Eva Gesteiro; David Escobar-Toledo; Rafael Torres-Peralta; Marc Roller; Amelia Guadalupe-Grau Journal: Int J Environ Res Public Health Date: 2021-05-22 Impact factor: 3.390
Authors: Xiao-Hong Li; Kristine C Y McGrath; Van H Tran; Yi-Ming Li; Colin C Duke; Basil D Roufogalis; Alison K Heather Journal: Evid Based Complement Alternat Med Date: 2013-06-16 Impact factor: 2.629